Creative Medical Technology Holdings, Inc. (CELZ) Financials
CELZ Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 9.4 million | 698595 |
| March 31, 2026 | 6.4 million | 307649 |
| Dec. 31, 2025 | 7.8 million | 284880 |
| Sept. 30, 2025 | 5.9 million | 261353 |
CELZ Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -1.5 million | ? |
| March 31, 2026 | -1.3 million | ? |
| Dec. 31, 2025 | -1.9 million | ? |
| Sept. 30, 2025 | -1.2 million | ? |
CELZ Net Income
No data available :(
CELZ Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 8.7 million | - | - |
| March 31, 2026 | 5.8 million | - | - |
| Dec. 31, 2025 | 7.2 million | - | - |
| Sept. 30, 2025 | 5.4 million | - | - |
CELZ Shares Outstanding
CELZ Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 459200 | - | - |
| March 31, 2026 | 125000 | 541658 | 888640 | - |
| Dec. 31, 2025 | 4 | 550077 | 1.4 million | - |
| Sept. 30, 2025 | - | 465154 | 776821 | - |
CELZ Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | 22918 |
| March 31, 2026 | - | 28855 |
| Dec. 31, 2025 | 3000 | 994 |
| Sept. 30, 2025 | - | 31059 |
CELZ
Price: $0.77
52 week price:
Earnings Per Share: -2.05 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 183800
Market Capitalization: 2.4 million